gms | German Medical Science

88th Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

24.05. - 27.05.2017, Erfurt

Head and neck malignant melanomas – clinical cases and treatment guidelines

Meeting Abstract

  • corresponding author Stefan Stoyanov - Ministry of Interior - Medical Institute, Sofia, Bulgaria
  • Georgi Chernev - MI-MI, Sofia, Bulgaria
  • Nikolay Damyanov - MI-MI, Sofia, Bulgaria
  • Iliya Lozev - MI-MI, Sofia, Bulgaria
  • Petar Kolev - MI-MI, Sofia, Bulgaria
  • Svetla Vasileva - MI-MI, Sofia, Bulgaria
  • Grigor Neofitov - MI-MI, Sofia, Bulgaria
  • Slavena Adamova - MI-MI, Sofia, Bulgaria
  • Katya Asenova - Military Medical Academy, Sofia, Bulgaria
  • Desislava Skerleva - Kyoto University, Kyoto, Japan

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. 88. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. Erfurt, 24.-27.05.2017. Düsseldorf: German Medical Science GMS Publishing House; 2017. Doc17hno201

doi: 10.3205/17hno201, urn:nbn:de:0183-17hno2015

Published: April 13, 2017

© 2017 Stoyanov et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Malignant melanomas are among the deadliest and fastest growing malignant tumors in human body. Although several decades ago they were considered rare, their frequency has increased dramatically in recent years.

Our aim is to present several of our own cases of malignant melanoma in head and neck area and outline treatment guidelines.

The extent of surgery is determined by the stage, location and size of the tumor: local excision; excision with sentinel lymph node biopsy; excision with selective modified or radical neck dissection. The advanced cases are treated by chemotherapy but the prognosis is poor. Promising seem to be the immuno-medications based on specific receptor antibodies.

Good collaboration with dermatologists is important for early diagnosis - a fundamental prerequisite for therapeutic success.

Der Erstautor gibt keinen Interessenkonflikt an.